Effective vaccines, treatment, and testing form three key components of the health care response to the COVID-19 pandemic. Important policy and regulatory issues include balancing safety and speed; equity and effectiveness; value and innovation.
On this page you will find a set of papers from Health Affairs’ special coverage of vaccines and treatment in November 2020, just as news of successful vaccine trials became public. These fast-track, peer-reviewed articles cover the development, approval and regulatory process; the variables around effectiveness; why we must invest in vaccine delivery strategies; how public and private leaders can ensure equitable access; and what to consider in pricing vaccines and treatments.
Health Affairs brought researchers, government and industry leaders together in the summer of 2020 to discuss vaccine and treatment innovation and equity. Questions of collaboration and competition surfaced at the event. Commentary in Health Affairs Blog includes the U.S. Food and Drug Administration (FDA) leadership response to COVID-19 at six months.
Related COVID‑19 Topics
COVID-19 Vaccines & Treatment Journal Articles
The COVID-19 Innovation System
March 2021
Blog
-
Addressing Antimicrobial Resistance—The Invisible Pandemic
April 28, 2021
Uneven Rollout Of COVID-19 Vaccinations In United States Prisons
April 15, 2021
What Are Foundations Doing To Help Understand And Diminish The Barriers To People Getting Available COVID-19 Vaccines?
April 9, 2021
Israel Owes Its COVID-19 Vaccination Success To A System of Universal Coverage And Community Infrastructure
March 18, 2021
Lessons In COVID-19 Vaccination From Israel
March 18, 2021
During The COVID-19 Pandemic, Prioritize Routine And Seasonal Vaccination For Health Care Personnel
March 17, 2021
Multimedia
